Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...
GlobalData on MSN
NG Biotech announces FDA approval for diagnostic assays
NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...
-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...
SLNB remains a key staging procedure in clinically node-negative melanoma and provides prognostic information that can guide adjuvant therapy discussions. Current NCCN guidelines recommend discussing ...
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
The coronavirus disease 2019 (COVID-19) pandemic continues as many parts of the world grapple with skyrocketing cases. The global toll has reached 72.4 million cases, and 1.61 million have lost their ...
A new multiplex real-time RT-PCR assay performs as well as the modified Centers for Disease Control and Prevention (CDC) assay, yet can test three times more patients per run, scientists report.
Morning Overview on MSN
Simple blood test may predict Alzheimer’s years before symptoms start
Researchers have built a blood-based “clock” that estimates when Alzheimer’s symptoms will likely begin, potentially years before any memory loss appears. The model, validated in two major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results